Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

202
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
202
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

162
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
162
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
128

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunoglobulin κ drives liver regeneration by stabilizing MYLK to maintain cytoskeletal integrity and promote hepatocyte proliferation.

Journal of translational internal medicine·2026
Same author

Comparative Analysis of Electrocautery Versus LigaSure Energy-based Device for Anterolateral Thigh Free Flap Dissection.

Plastic and reconstructive surgery. Global open·2026
Same author

Smartphone-Based Proactive Self-Screening for Ocular Surface Malignancies: A Nonrandomized Clinical Trial.

JAMA ophthalmology·2026
Same author

<i>Trichinella spiralis</i> HSP70 Mediates Mice Immune Responses via TLR2/MyD88/ERK Signaling Pathway.

Transboundary and emerging diseases·2026
Same author

Inhibition of starch retrogradation in fermented rice cakes during simulated cold chain logistics.

Food chemistry·2026
Same author

Chlorogenic acid modulates gut microbiota and metabolites to alleviate intrahepatic cholestasis of pregnancy: Insights from 16S rRNA sequencing and metabolomics.

Biochemistry and biophysics reports·2026
Same journal

Uncommon initial presentation of a gastric mass in a patient with primary plasma cell leukemia: a case report.

BMC gastroenterology·2026
Same journal

Examining the effect of nurse navigation programme on stoma adjustment, quality of life, and prevention of complications in patients with stoma: a randomized controlled trial.

BMC gastroenterology·2026
Same journal

Determinants of eligibility for second-line chemotherapy following gemcitabine plus nab-paclitaxel therapy in patients with unresectable pancreatic cancer: a retrospective study.

BMC gastroenterology·2026
Same journal

Integrating WGCNA and machine learning to identify and validate key biomarkers in MASLD.

BMC gastroenterology·2026
Same journal

Predictive factors and nomogram for post-endoscopic retrograde cholangiopancreatography pancreatitis.

BMC gastroenterology·2026
Same journal

Associations between childhood behavior and current cognitive and emotional function in adults with irritable bowel syndrome-a cross sectional retrospective study.

BMC gastroenterology·2026
See all related articles

Related Experiment Video

Updated: Sep 13, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.8K

Concurrent nonalcoholic fatty liver disease may decrease liver fibrosis severity in patients with primary biliary

Wenhui Ren1, Zilong Wang2, Xinyue Liu3

  • 1Department of Clinical Epidemiology, Peking University People's Hospital, No.11 Xizhimen South Street, Beijing, 100044, China.

BMC Gastroenterology
|July 30, 2025
PubMed
Summary
This summary is machine-generated.

Nonalcoholic fatty liver disease (NAFLD) in primary biliary cholangitis (PBC) patients did not affect biochemical response to ursodeoxycholic acid (UDCA). However, concurrent NAFLD may improve liver fibrosis and long-term transplant-free survival in PBC.

Keywords:
Biochemical responseLong-term prognosisNonalcoholic fatty liver diseasePrimary biliary cholangitisProgressive liver fibrosis

More Related Videos

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

16.3K
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.1K

Related Experiment Videos

Last Updated: Sep 13, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.8K
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

16.3K
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.1K

Area of Science:

  • Hepatology
  • Internal Medicine
  • Gastroenterology

Background:

  • Primary biliary cholangitis (PBC) is a chronic liver disease.
  • Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent.
  • The impact of NAFLD on PBC progression and prognosis is not fully understood.

Purpose of the Study:

  • To investigate the influence of NAFLD on the progression and prognosis of PBC.
  • To assess how concurrent NAFLD affects biochemical response to UDCA treatment in PBC patients.
  • To evaluate the impact of NAFLD on liver fibrosis and long-term survival in PBC.

Main Methods:

  • Retrospective study of PBC patients, identifying those with concurrent NAFLD.
  • Primary outcome: complete biochemical response to UDCA (Paris criteria).
  • Secondary outcomes: non-invasive fibrosis scores (APRI, FIB-4), and transplantation-free survival (GLOBE score).

Main Results:

  • 24.0% of PBC patients (87/363) had concurrent NAFLD.
  • No significant difference in biochemical response to UDCA between PBC and PBC+NAFLD groups.
  • PBC+NAFLD group showed improved fibrosis scores (APRI, FIB-4) and better transplant-free survival rates.

Conclusions:

  • Concurrent NAFLD does not significantly alter biochemical response to UDCA in PBC.
  • NAFLD may be associated with improved liver fibrosis and better long-term prognosis in PBC patients.
  • Further research is warranted to elucidate the mechanisms behind these findings.